AstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab Ruchika Sharma12 April 2023 3:44 PM ISTBeyfortus (nirsevimab), an investigational long-acting antibody designed to protect all infants against RSV infections from birth through their first...
AstraZeneca announces positive results from ovarian cancer combo therapy trial Ruchika Sharma7 April 2023 11:30 AM ISTThe safety and tolerability of these combinations are broadly consistent with that observed in prior clinical trials and the known profiles of the...
Pay AstraZeneca royalties on total sales of ovarian cancer drug Zejula: UK Court orders GSK's Tesaro Ruchika Sharma6 April 2023 10:00 AM ISTUK: A UK court on Wednesday ordered GSK's Tesaro to pay rival AstraZeneca royalties on total sales of ovarian cancer drug Zejula, in a win for the...
AstraZeneca Ultomiris recommended for marketing approval in EU for neuromyelitis optica spectrum disorder Ruchika Sharma4 April 2023 4:00 PM ISTNMOSD is a rare and debilitating autoimmune disease that affects the central nervous system, including the spine and optic nerves.
AstraZeneca completes global license agreement with KYM Biosciences for CMG901 Ruchika Sharma1 April 2023 10:00 AM ISTUK: AstraZeneca has completed an exclusive global license agreement with KYM Biosciences Inc. for CMG901, a potential first-in-class antibody drug...
AstraZeneca Calquence gets conditional nod in China for adults with previously treated mantle cell lymphoma Ruchika Sharma26 March 2023 10:00 AM ISTMantle cell lymphoma is a rare B-cell malignancy subtype and is typically clinically aggressive with a poor prognosis.
All SAEs including death should be reported: CDSCO Panel tells AstraZeneca about Durvalumab Dr. Divya Colin25 March 2023 6:00 PM ISTNew Delhi: Granting the protocol amendment proposal presented by drug major AstraZeneca for anticancer drug Durvalumab, the Subject Expert Committee...
Conduct Phase III CT : CDSCO panel tells AstraZeneca for anticancer drug Olaparib Film coated Tablet Dr. Divya Colin17 March 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the drug major...
AstraZeneca Gets CDSCO Panel nod to import, market Trastuzumab deruxtecan for breast cancer Dr. Divya Colin16 March 2023 6:00 PM ISTNew Delhi: Granting the local Phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
AstraZeneca Enhertu shows clinically meaningful, durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial Ruchika Sharma8 March 2023 1:00 PM ISTHER2 is a tyrosine kinase receptor protein expressed on the surface of various tissue cells throughout the body and is involved in normal cell growth.
AstraZeneca concludes acquisition of CinCor Pharma Ruchika Sharma26 Feb 2023 2:30 PM ISTUK: AstraZeneca has announced the successful completion of the acquisition of CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical...
AstraZeneca enters license agreement with KYM Biosciences for CMG901 Ruchika Sharma26 Feb 2023 10:00 AM ISTUK: AstraZeneca and KYM Biosciences Inc. have entered into a global exclusive licence agreement for CMG901, a potential first-in-class antibody...
